NovoCure Cash Flow Statement Analysis

Operating, investing, and financing activities in billions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for NovoCure Limited (NVCR) - Annual data in billions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Operating Activities
Net Income-0.17-0.21-0.09-0.060.02-0.01-0.06
Depreciation & Amortization0.01-0.010.010.010.010.010.01
Stock Based Compensation0.160.120.110.090.080.000.00
Change in Working Capital0.000.000.010.03-0.01-0.020.01
Change in Accounts Receivable-0.030.030.000.01-0.030.000.00
Change in Inventory0.00-0.010.000.000.000.000.00
Change in Accounts Payable0.020.010.010.030.030.000.00
Change in Other Working Capital0.000.000.00-0.010.000.000.00
Other Operating Activities0.000.15-0.010.100.000.050.00
Net Cash from Operating Activities-0.03-0.070.030.080.100.030.00
Investing Activities
Capital Expenditures-0.040.03-0.020.02-0.010.01-0.01
Purchases of Investments-0.10-1.00-0.12-0.12-0.460.000.00
Sales/Maturities of Investments0.781.21-0.12-0.12-0.46-0.040.00
Net Cash from Investing Activities-0.140.18-0.14-0.14-0.47-0.05-0.01
Financing Activities
Debt Repayment-0.010.000.000.00-0.150.00-0.10
Common Stock Issued0.010.000.020.000.030.000.00
Other Financing Activities0.000.000.000.000.000.000.00
Net Cash from Financing Activities0.090.020.020.030.440.060.07
Summary
Effect of Forex Changes on Cash0.000.000.000.000.000.000.00
Net Change in Cash-0.080.13-0.09-0.040.070.040.06
Cash at Beginning of Period0.240.120.210.250.180.140.08
Cash at End of Period0.17-0.100.120.210.250.180.14
Free Cash Flow-0.07-0.100.010.060.080.02-0.01
Supplemental Disclosures
Interest Paid0.010.000.000.000.010.010.01
Income Taxes Paid0.020.010.010.000.000.010.02